Form 13-F position report

NGM BIOPHARMACEUTICALS INC

Reported by Candriam S C A

NGM CUSIP 62921N105 Manager CIK 0001537014

Reported 0 shares, down 152,187 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 17 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0
2022-03-31 3312000
2022-06-30 2784000
2022-09-30 3716000
2022-12-31 1888245
2023-03-31 571515
2023-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for NGM BIOPHARMACEUTICALS INC held by Candriam S C A.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2023 Reduced 0 -152,187 (-100.0%) 0 $0 2023-08-08
Q1 2023 Reduced 152,187 -223,975 (-59.5%) < 0.01% $571,515 2023-05-12
Q4 2022 Added 376,162 +92,112 (32.4%) 0.01% $1,888,245 2023-02-13
Q3 2022 Added 284,050 +66,863 (30.8%) 0.03% $3,716,000 2022-11-10
Q2 2022 Unchanged 217,187 0 (0.0%) 0.02% $2,784,000 2022-08-03
Q1 2022 New 217,187 +217,187 (0.0%) 0.02% $3,312,000 2022-05-13
Q4 2021 Reduced 0 -564,059 (-100.0%) 0 $0 2022-02-10
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

133 managers reported NGM BIOPHARMACEUTICALS INC for Q2 2023.

Managers reporting NGM BIOPHARMACEUTICALS INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Column Group LLC Unchanged 18,136,735 0 18.23% $46,974,144 11 qtrs
EcoR1 Capital LLC Unchanged 6,435,518 0 0.41% $16,667,992 6 qtrs
BlackRock Inc Added 4,633,005 +526,863 < 0.01% $11,999,484 17 qtrs
VANGUARD GROUP INC Reduced 2,793,260 -885,263 < 0.01% $7,234,544 17 qtrs
StepStone Group LP Unchanged 1,573,357 0 0.75% $4,074,995 8 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 1,138,843 +200,409 0.01% $2,948,000 9 qtrs
MORGAN STANLEY Added 898,132 +41,823 < 0.01% $2,326,163 17 qtrs
STATE STREET CORPORATION Added 856,566 +117,214 < 0.01% $2,218,506 17 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 850,956 +60,119 < 0.01% $2,203,976 17 qtrs
Nuveen Asset Management LLC Added 781,337 +12,453 < 0.01% $2,023,663 17 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 08, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.